AbbVie
The Precision Medicine Lead - Oncology role involves leading the development and execution of precision medicine strategies for oncology programs in early and late-stage clinical development. The position requires collaboration with global teams to design and implement translational research and clinical biomarker strategies, ensuring successful drug-diagnostic co-development. The role demands strong leadership and communication skills to drive effective decisions with cross-functional stakeholders and advance the oncology pipeline.
Headquarters
North Chicago, Illinois, United States
Company Size
10001+ employees
Founded
2013
AbbVie is a global, research-driven biopharmaceutical company that was spun off from Abbott Laboratories in 2013. It develops and commercializes specialty medicines across immunology, oncology, neuroscience, eye care and virology — with Humira historically its flagship product — and has broadened its portfolio through acquisitions (notably Allergan) and strategic collaborations. AbbVie emphasizes a robust R&D pipeline, targeted therapies, and global commercial and manufacturing capabilities. The company focuses on delivering long-term treatment options for complex, chronic and serious diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AbbVie.
AbbVie didn’t post a salary, so this is our estimate from similar listings.
16% above the average for this role
Translational Medicine Director
Isomorphic Labs
Director, Oncology Translational Medicine, Clinical Biomarkers
GSK plc
Translational Medicine Lead, Associate Director, Oncology
AstraZeneca
Biomarker and Precision Medicine Lead
Sanofi
Director, Translational Medicine, Neurology
Bristol Myers Squibb
Executive Director, Oncology MDT Biomarker Lead
GSK plc